Sign In
Buy KPTI
$9.00
-0.230 (-2.49%)
At Close: Jun 03, 2026
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
GlycoMimetics (GLYC) Receives a Rating Update from a Top Analyst
04:11pm, Friday, 01'st May 2020
H.C. Wainwright analyst Edward White maintained a Buy rating on GlycoMimetics (GLYC) today and set a price target of $16.00. The company's shares closed
GlycoMimetics (GLYC) Receives a Rating Update from a Top Analyst
04:11pm, Friday, 01'st May 2020
H.C. Wainwright analyst
Edward White
maintained a
Buy
rating on GlycoMimetics (
GLYC
–
Research Report
) today and set a price target of
$16.00
. The company’s shares closed last Friday at $2.57,
Veja as oportunidades de emprego no Sine em 7 cidades de SC
02:07pm, Friday, 01'st May 2020
Há vagas em Blumenau, Chapecó, Florianópolis, Itajaí, Joinville, Criciúma e Lages.
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioMarin Pharmaceutical (BMRN), Agios Pharma (AGIO) and
H.C. Wainwright Reiterates a Buy Rating on Puma Biotechnology (PBYI)
11:12am, Friday, 01'st May 2020
H.C. Wainwright analyst Edward White reiterated a Buy rating on Puma Biotechnology (PBYI) today and set a price target of $15.00. The company's shares
H.C. Wainwright Reiterates a Buy Rating on Puma Biotechnology (PBYI)
11:12am, Friday, 01'st May 2020
H.C. Wainwright analyst
Edward White
reiterated a
Buy
rating on Puma Biotechnology (
PBYI
–
Research Report
) today and set a price target of
$15.00
. The company’s shares closed last Thursday at
Acceleron Pharma (XLRN) Receives a Buy from H.C. Wainwright
11:11am, Friday, 01'st May 2020
In a report released today, Edward White from H.C. Wainwright maintained a Buy rating on Acceleron Pharma (XLRN), with a price target of $137.00. The
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 56'5(c)(4)
12:00am, Friday, 01'st May 2020PROMETRIKA and Karyopharm: Partners in Global COVID-19 Trial
05:03pm, Thursday, 30'th Apr 2020
Partners in Global COVID-19 Trial
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Universal Health (UHS), Deciphera Pharmaceuticals (DCPH)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Universal Health (
UHS
–
Research Report
), Deciphera Pharmaceuticals (
DCPH
–
Research Report
) an
Analysts Offer Insights on Healthcare Companies: Vaxart (VXRT), Karyopharm Therapeutics (KPTI) and Krystal Biotech (KRYS)
11:15am, Thursday, 30'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vaxart (VXRT), Karyopharm Therapeutics (KPTI) and Krystal
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vaxart (
VXRT
–
Research Report
), Karyopharm Therapeutics (
KPTI
–
Research Report
) and Krystal B
